J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levêque, D.
Right arrow Articles by Jehl, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levêque, D.
Right arrow Articles by Jehl, F.

DRUG METABOLISM/TRANSPORT

Molecular Pharmacokinetics of Catharanthus (Vinca) Alkaloids

Dominique Levêque, PharmD, PhD and François Jehl, PharmD, PhD

From the Pharmacy, Hôpital Hautepierre, Strasbourg, France, and the Institute of Bacteriology, Strasbourg, France.

This review focuses on the published data regarding the molecular determinants (enzymes, transporters, orphan nuclear receptors) of Catharanthus (vinca) alkaloids pharmacokinetics in humans. The clinical impact of these determinants (drug disposition, drug-drug interactions) is also discussed.


Key Words: Catharanthus alkaloidsvinblastinevincristinevindesinevinorelbineCYP450drug transportersorphan nuclear receptorsdrug-drug interactions

Address for reprints: Address for correspondence: Dominique Levêque, Pharmacy-Pharmacology, Hôpital Hautepierre, Avenue Molière, 67000 Strasbourg, France; e-mail: dominique.leveque{at}chru-strasbourg.fr.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Clinical Pharmacology